Castle Biosciences, Inc. (CSTL) Reports Q4 Loss, Tops Revenue Estimates
https://www.zacks.com/stock/news/2233438/castle-biosciences-inc-cstl-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2233438
Feb 28, 2024 - Castle Biosciences, Inc. (CSTL) delivered earnings and revenue surprises of 88.10% and 28.85%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
0
Mirum Pharmaceuticals, Inc. (MIRM) Reports Q4 Loss, Tops Revenue Estimates
https://www.zacks.com/stock/news/2233406/mirum-pharmaceuticals-inc-mirm-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2233406
Feb 28, 2024 - Mirum Pharmaceuticals, Inc. (MIRM) delivered earnings and revenue surprises of -94.12% and 4.23%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
0
Establishment Labs Holdings Inc. (ESTA) Reports Q4 Loss, Tops Revenue Estimates
https://www.zacks.com/stock/news/2233411/establishment-labs-holdings-inc-esta-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2233411
Feb 28, 2024 - Establishment Labs Holdings Inc. (ESTA) delivered earnings and revenue surprises of 16.84% and 0.06%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
0
Red Robin (RRGB) Reports Q4 Loss, Tops Revenue Estimates
https://www.zacks.com/stock/news/2233412/red-robin-rrgb-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2233412
Feb 28, 2024 - Red Robin (RRGB) delivered earnings and revenue surprises of -53.49% and 1.40%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
0
Marqeta (MQ) Reports Q4 Loss, Tops Revenue Estimates
https://www.zacks.com/stock/news/2233403/marqeta-mq-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2233403
Feb 28, 2024 - Marqeta (MQ) delivered earnings and revenue surprises of 11.11% and 7.66%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
0
TJX tops earnings estimates but issues light guidance ahead of uncertain growth path
https://www.cnbc.com/2024/02/28/tjx-companies-tjx-earnings-q4-2024.html
Feb 28, 2024 - Off-price giant TJX Companies, which runs TJ Maxx, Marshall's and Homegoods, saw sales rise 13% during its holiday quarter.
0
Top Research Reports for NVIDIA, Visa & Amgen
https://www.zacks.com/commentary/2232860/top-research-reports-for-nvidia-visa-amgen?cid=CS-ZC-FT-research_daily-2232860
Feb 28, 2024 - Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Visa Inc. (V) and Amgen Inc. (AMGN).
0
Are You Looking for a Top Momentum Pick? Why Ralph Lauren (RL) is a Great Choice
https://www.zacks.com/stock/news/2233363/are-you-looking-for-a-top-momentum-pick-why-ralph-lauren-rl-is-a-great-choice?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2233363
Feb 28, 2024 - Does Ralph Lauren (RL) have what it takes to be a top stock pick for momentum investors? Let's find out.
0
Inhibrx, Inc. (INBX) Reports Q4 Loss, Tops Revenue Estimates
https://www.zacks.com/stock/news/2233288/inhibrx-inc-inbx-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2233288
Feb 28, 2024 - Inhibrx, Inc. (INBX) delivered earnings and revenue surprises of -61.68% and 1,534%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
0
Why FirstEnergy (FE) is a Top Momentum Stock for the Long-Term
https://www.zacks.com/stock/news/2233261/why-firstenergy-fe-is-a-top-momentum-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2233261
Feb 28, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
0